BENZOTHIOPHENE COMPOUNDS

The present invention relates to compounds of formula (I) wherein R1 is -H, - OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of which may be optionally substituted with 1-3 substituents independently selected from the group halo , - OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); X is -CH2-, -CO-, or -CH(OH)-; n is 2 or 3' and R3 is 1- piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl- 1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1- hexamethyleneimino; or a pharmaceutically acceptable salt thereof. The present invention further relates to pharmaceutical compositions containing compounds of formula (I), optionally containing estrogen or progestin, and the use of such compounds, alone, or in combination with estrogen or progestin, for alleviating the symptoms of post-menopausal syndrome, particularly osteoporosis cardiovascular related pathological conditions, and estrogen-dependent cancer. The compounds of the present invention also are useful for inhibiting uterine fibroid disease and endometriosis in women and aortal smooth muscle cell proliferation, particularly restenosis, in humans.